Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NH › North Conway › NPI 1700864709
Hospital

Memorial Hospital

Memorial Hospital was paid $7.42M by Medicaid between Jan 2018 and Dec 2024, across 173 billing codes. Its largest line is 99284, emergency room visit (serious) — 23% of everything it billed.

33Billing provider infoMEMORIAL HOSPITAL
NORTH CONWAY, NH 03860
33aNPI1700864709assigned 01/09/2006
33bProvider typeCritical Access Hospital
28Total paid$7.42M
24GClaims220,892
24DCodes billed173
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in New Hampshire

Rank by total paid#2 of 9
Median peer was paid$5.24M
This provider vs. median1.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201834,840$753K
201937,953$1.13M
202034,586$1.19M
202145,372$1.83M
202236,873$1.62M
202316,074$448K
2024incomplete15,194$449K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 23% 10,607 6,978 $1.68M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.8% 4,682 2,672 $730K
74177 Computed tomography, abdomen and pelvis; with contrast material 7.9% 1,740 1,445 $588K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.9% 6,596 4,697 $583K
70450 Computed tomography, head or brain; without contrast material 4.7% 1,656 1,267 $349K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.9% 5,158 3,743 $216K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.9% 3,392 2,710 $212K
G0378 Hospital observation service, per hour 2.2% 551 379 $165K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 2.0% 554 485 $145K
71046 Radiologic examination, chest; 2 views 1.9% 2,949 2,306 $140K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.8% 2,632 2,136 $133K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.8% 4,140 1,358 $131K
161 more codes
77067 Screening mammography, bilateral, including computer-aided detection 1.7% 496 $130K
96375 Therapeutic injection; each additional sequential IV push 1.7% 3,306 $128K
96361 Intravenous infusion, hydration; each additional hour 1.6% 3,542 $121K
71275 Computed tomographic angiography, chest, with contrast material 1.6% 156 $120K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.6% 2,521 $119K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.2% 3,876 $91K
76830 Ultrasound, transvaginal 1.1% 380 $81K
76819 Fetal biophysical profile; without non-stress testing 1.0% 373 $76K
80053 Comprehensive metabolic panel 1.0% 14,580 $76K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 382 $74K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,164 $66K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 16,515 $63K
71045 Radiologic examination, chest; single view <1% 2,075 $50K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 681 $49K
72125 Computed tomography, cervical spine; without contrast material <1% 141 $49K
59025 Fetal non-stress test <1% 506 $45K
84443 Thyroid stimulating hormone (TSH) <1% 4,081 $38K
36415 Collection of venous blood by venipuncture <1% 17,636 $36K
99214 Doctor's office visit, returning patient (more involved) <1% 3,081 $35K
77063 Screening digital breast tomosynthesis, bilateral <1% 494 $34K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,406 $34K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 589 $32K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 974 $31K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 214 $30K
73630 <1% 441 $27K
76801 <1% 91 $23K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 110 $23K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 891 $23K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 3,980 $22K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,297 $22K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,523 $21K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 950 $21K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 953 $21K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,846 $20K
99213 Doctor's office visit, returning patient (routine) <1% 3,266 $18K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 925 $18K
80061 Lipid panel <1% 1,991 $17K
80048 Basic metabolic panel (calcium, ionized) <1% 3,953 $16K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 49 $15K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 2,009 $15K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 323 $15K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 3,850 $14K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,300 $14K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 566 $13K
84484 <1% 3,752 $13K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 102 $12K
80306 <1% 1,145 $9K
87070 <1% 1,414 $9K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 964 $9K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 50 $9K
83690 <1% 2,498 $9K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 285 $9K
85027 <1% 2,480 $9K
83735 <1% 3,147 $8K
84703 <1% 1,479 $8K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 356 $8K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 309 $7K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 37 $7K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 2,777 $7K
86140 <1% 2,634 $7K
71250 <1% 15 $7K
96376 <1% 172 $7K
97161 <1% 98 $6K
81001 <1% 4,219 $6K
73502 <1% 139 $6K
94762 <1% 365 $6K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 2,461 $6K
87040 <1% 1,201 $6K
J7030 Infusion, normal saline solution , 1000 cc <1% 348 $6K
73560 <1% 109 $6K
83036 Hemoglobin; glycosylated (A1C) <1% 1,199 $5K
73030 <1% 104 $5K
87077 <1% 1,226 $5K
99203 Doctor's office visit, new patient (routine) <1% 321 $5K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 214 $5K
83880 <1% 532 $5K
86850 <1% 720 $5K
85610 <1% 2,978 $5K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 563 $5K
87481 <1% 309 $5K
73610 <1% 75 $5K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,207 $4K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 14 $4K
87186 <1% 871 $4K
83605 <1% 1,127 $4K
82728 <1% 410 $4K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 187 $4K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring <1% 23 $4K
87511 <1% 210 $4K
87400 <1% 381 $4K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 65 $3K
84702 <1% 260 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,857 $3K
82607 <1% 364 $3K
86803 <1% 287 $3K
72100 <1% 40 $3K
J7120 Ringers lactate infusion, up to 1000 cc <1% 119 $2K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 12 $2K
81003 <1% 1,918 $2K
86780 <1% 209 $2K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 21 $2K
84439 <1% 295 $2K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 128 $2K
J3490 Unclassified drugs <1% 569 $2K
82746 <1% 128 $2K
82948 <1% 1,565 $2K
83550 <1% 287 $2K
86901 <1% 723 $2K
86900 <1% 704 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 792 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 220 $1K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 78 $1K
87340 <1% 160 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 245 $1K
83540 <1% 308 $1K
87081 <1% 262 $1K
85651 <1% 557 $1K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 294 $1K
85380 <1% 134 $1K
81025 <1% 261 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 351 $935.82
J2704 Injection, propofol, 10 mg <1% 81 $934.26
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 808 $916.96
73130 <1% 17 $901.30
93000 <1% 15 $890.80
85730 <1% 376 $890.46
87653 <1% 34 $839.41
J0690 Injection, cefazolin sodium, 500 mg <1% 78 $810.60
83655 <1% 66 $726.28
73140 <1% 15 $679.49
86762 <1% 59 $671.61
86618 <1% 57 $667.77
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 18 $616.36
90715 <1% 14 $603.97
11721 <1% 242 $549.76
73110 <1% 17 $535.26
87205 <1% 153 $417.39
82962 <1% 306 $391.35
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 110 $382.53
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 307 $363.70
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 17 $314.18
80320 <1% 16 $310.50
J1650 Injection, enoxaparin sodium, 10 mg <1% 33 $195.30
82950 <1% 45 $191.95
88142 <1% 12 $187.30
J2060 Injection, lorazepam, 2 mg <1% 70 $149.18
99215 Doctor's office visit, returning patient (complex) <1% 20 $134.05
81002 <1% 132 $123.90
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 14 $97.21
80050 General health panel <1% 12 $92.76
11720 <1% 44 $82.55
85652 <1% 37 $80.40
99307 <1% 35 $77.25
84550 <1% 15 $50.24
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 47 $49.73
84100 <1% 14 $36.38
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 37 $21.65
A9270 Non-covered item or service <1% 16 $6.29
Q0247 Injection, sotrovimab, 500 mg <1% 23 $0.22
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 888 $0.03
Q0244 Injection, casirivimab and imdevimab, 1200 mg <1% 12 $0.02

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCLAUGHLIN, DIANA (CHIEF FINANCIAL OFFICER)
Same official

Other billing entities under MCLAUGHLIN, DIANA

Full network →
ProviderLocationPaid
Memorial HospitalNorth Conway, NH$2.18M
Diana Mclaughlin, M.D., PANaples, FL$775K
Memorial HospitalNorth Conway, NH$744K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.